Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal Study

Since SARS-CoV-2 emerged in 2019, strict monitoring of post-COVID-19 patients in order to ensure the early detection of sequelae and/or chronic organ damage that could been associated with the infection has been essential. Potential involvement of the NO pathway in the development of post-COVID-19 l...

Descripción completa

Detalles Bibliográficos
Autores principales: Cameli, Paolo, Bargagli, Elena, Bergantini, Laura, d’Alessandro, Miriana, Giugno, Bruna, Gentili, Francesco, Sestini, Piersante
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471694/
https://www.ncbi.nlm.nih.gov/pubmed/34572982
http://dx.doi.org/10.3390/antiox10091350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471694/
https://www.ncbi.nlm.nih.gov/pubmed/34572982
http://dx.doi.org/10.3390/antiox10091350

Ejemplares similares